Pokethebear

CRISPR - Genetic Improvements

Long
NASDAQ:CRSP   CRISPR Therapeutics AG
EDIT and CRSP
CRISPR-Cas9, -Cas11, -Cas12 genetic improvements for bio-pharma partnerships
The next big thing to improving and repairing defects in you RNA

Currently at Fibretracement 0.618 and in spot to move up or down, depending on big money theory...wahahah!
but there's enough small money to pull it down, just saying for disclosure.
Comment: CRISPR just got FDA approval for first clinical trial in gene editing.
Comment: Dropping to 786fibretracement at 29.80 or lower. Set alert to 30, 20, and 18. Buying all I can below 20 and easy 10bagger in next decade.
Comment: Closing in on 30, watch VIX to dip below 15 for buying flury.
Comment: Target entry at 786 retracement and below $30. Expecting no increase in fed rate this week, maybe next. Gov. shutdown looming Friday leaves Fed. shifting as my prognostication.